Navigation Links
IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery

MOUNTAIN VIEW, Calif., Oct. 11 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced commercial availability of a new family of Adjustable & Intuitive EndoProbe laser handpieces for use with the Company's laser platforms in vitreoretinal surgery. The Adjustable & Intuitive Laser Probes speed up treatments by allowing continuous, intuitive adjustment of the fiber optic over a wide range of angles for full coverage of the peripheral retina without requiring removal and reinsertion of the probe from the eye or requiring frequent adjustments of laser power settings. In addition, its innovative design and construction allows surgeons to treat further away from the retina and/or at a lower power setting.

"The introduction of this product under a newly issued U.S. patent reinforces our strategy of building upon our position as the global leader in laser delivery instrumentation and to continue to increase the value of our consumable instrumentation line," said Theodore A. Boutacoff, President and CEO.

"We will continue to focus on introducing new products that differentiates us from our competitors and leverage our existing sales channel to increase our revenues."

This product is protected by U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.


IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit our website at

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, relating to the Company's plans to focus on new products and increase revenues.  These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors. Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended January 2, 2010 which was filed with the Securities and Exchange Commission and in our Quarterly Report on Form 10-Q for the fiscal quarter ended July 3, 2010. Forward-looking statements contained in this announcement are made as of this date and will not be updated.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IRIDEX Announces Second Quarter 2010 Conference Call and Release Date
2. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
3. IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
4. IRIDEX Announces First Quarter 2010 Conference Call and Release Date
5. IRIDEX Reports Fourth Quarter and Full Year 2009 Financial Results
6. IRIDEX Announces Fourth Quarter and Full Year 2009 Conference Call and Release Date
7. Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
8. IRIDEX Introduces IQ 532 Dual Port Green Laser System at the American Academy of Ophthalmology
9. IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology
10. IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting
11. TriReme Medical Announces $17 Million Series D Financing
Post Your Comments:
(Date:12/1/2015)... Virginia , 1 de diciembre de ... en tecnología para cuchillas de precisión, develó ... programa de identidad de marca. El nuevo ... el diseño y la ingeniería de productos ... la diferencia". ...
(Date:12/1/2015)... 1, 2015 Breg, Inc ., a ... today that it has been awarded three contracts by ... by Novation will have access to improved pricing for ... and soft goods dedicated to advancing orthopedic care.  ... aging U.S. population, rising prevalence of chronic conditions and ...
(Date:12/1/2015)... India , December 1, 2015 ... a new market research report "Nucleic Acid Labeling Market ... (PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse ... 2020", published by MarketsandMarkets, The global market is expected ... 1,271.8 Million in 2015, growing at a CAGR of ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... For many X-rays taken at hospitals, doctors’ ... by the radiologist. The marking utensils are so small, however, they are difficult ... way to alleviate this problem. , He developed the patent-pending MARK N SHOW ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... Health Center of Excellence (BHCOE) today announced that the organization has awarded Education ... San Francisco, with a Distinguished Award. The award celebrates exceptional special needs providers ...
(Date:12/1/2015)... Burlington, MA (PRWEB) , ... December 01, 2015 , ... ... the release of Clarity, the latest addition to the devices for sale in the ... technologies, 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform ...
(Date:12/1/2015)... ... , ... XTC Semifinals 2016 - CES, Las Vegas, Nevada - ... CES 2016, the world’s largest Consumer Electronic Show, where they will present to a ... of Pacific Investments Veronica Serra, and venture capitalist Tim Draper among many other top ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Nurotron Biotechnology Co., ... its largest order to date. , The order will be from the China ... Venus Cochlear Implant System is an effective solution for children and adults suffering from ...
Breaking Medicine News(10 mins):